Friday · October 9, 2026
Emerging

4 Gut Bacteria Linked to Kidney Stone Risk, Genetic Study Finds

A two-sample Mendelian randomization study spanning genetic data from hundreds of thousands of people found four gut bacteria taxa causally linked to kidney stone risk, one raising it and three lowering it, adding genetic weight to a long-suspected gut-kidney connection.

4 Gut Bacteria Species Tied to Kidney Stone Risk in Genetic Study

If you've ever passed a kidney stone and wondered why it happened despite drinking enough water and watching your diet, a new line of evidence points somewhere unexpected: your gut bacteria. Researchers have used a large-scale genetic analysis to test whether the trillions of microbes living in your intestines (the gut microbiota) don't just correlate with kidney stone disease but actually help cause it. Their answer, published in the Urology Journal, is that four specific bacterial groups appear to nudge kidney stone risk up or down, and the genetic method used here makes the link harder to write off as coincidence.

Key takeaways

  • A genetic analysis found four gut bacteria groups causally linked to kidney stone risk: three (Lentisphaeria, Oscillibacter, Victivallales) were tied to lower risk, one (Olsenella) was tied to higher risk.
  • The method, two-sample Mendelian randomization, uses genetic data instead of direct observation, which helps rule out the usual "which came first" problem in gut-health studies.
  • The effects were modest (odds ratios between 0.79 and 1.26) and the authors call the findings hypothesis-generating, not proof that changing your gut bacteria will change your stone risk.
  • This is genetic evidence, not a clinical trial. No probiotic, diet, or supplement has been shown to replicate these effects in a real person.

Four Gut Bacteria Species Linked to Kidney Stone Risk

Researchers identified four gut bacteria taxa causally linked to kidney stone disease (KSD) risk, three of which appeared protective and one of which raised risk. Using Mendelian randomization, a genetic epidemiology method that uses naturally occurring DNA variation to test for cause and effect, the team found that higher genetically predicted levels of the bacterial class Lentisphaeria (odds ratio 0.82), the genus Oscillibacter (odds ratio 0.79), and the order Victivallales (odds ratio 0.82) were each linked to a lower risk of kidney stones. The genus Olsenella ran the other direction, with higher levels linked to a 26% higher relative risk (odds ratio 1.26). These results held up after the researchers reran the analysis with several different statistical methods and removed genetic variants that looked like they were influencing stone risk through some pathway other than the bacteria themselves.

Why Recurrent Stone Formers Should Take Note

Kidney stone disease is common and prone to coming back, which is exactly why a new causal lead matters to anyone who has already had one. Kidney stones are among the most common urologic conditions, and people who've had one are more likely to form another. The study's authors note that around half of patients experience a recurrence within five years of their first stone, often without a clear reason why despite following standard advice on fluids and diet. Roughly three-quarters of kidney stones are made of calcium oxalate, and oxalate is a byproduct of how the body, and its gut bacteria, break down certain nutrients. That's the biological thread this study is pulling on: if specific bacteria genuinely shift oxalate handling or other stone-forming pathways, they become a plausible new piece of the puzzle for people whose stones keep coming back for no obvious reason.

Two-Sample Mendelian Randomization Explained

The study's credibility rests on a genetic instrumental-variable method applied to two very large, independent datasets rather than on directly observing people's gut bacteria and stone outcomes together. The gut microbiota data came from a genome-wide association study of 18,340 participants across 24 cohorts in multiple countries. The kidney stone data came from separate European biobanks (EstBB, FinnGen, and Lifelines) totaling 284,598 people with kidney stones and 480,873 controls without them. Because the two datasets are independent and the genetic variants used as stand-ins for bacteria levels are fixed at conception, the design sidesteps a common problem in gut-health research: it's hard to know whether stones changed a person's bacteria or bacteria changed a person's stone risk. The researchers also ran the analysis in reverse, testing whether genetic predisposition to kidney stones changes gut bacteria levels, and found no significant association in either direction for any of the four taxa, which supports the bacteria-to-stones direction over the reverse.

What This Means If You've Had Kidney Stones

For someone managing recurrent stones, this study is a signal worth knowing about, not a treatment plan. None of the four bacteria identified here have an approved probiotic, supplement, or clinical protocol tied to kidney stone prevention, and the authors are explicit that their results are "hypothesis-generating." What it does add is a genetic reason to take the gut-stone connection seriously if you're already discussing recurrent stones with a urologist or nephrologist, particularly around diet, hydration, and any history of antibiotic use, since antibiotics are known to disrupt gut bacteria more broadly. It's also worth knowing that a well-studied gut microbe called Oxalobacter formigenes, which specializes in breaking down oxalate in the intestine, was not one of the four bacteria flagged in this particular study, a reminder that the gut-stone relationship likely involves more than one microbial player.

Key Limitations of This Genetic Evidence

The biggest caveat is built into the method: Mendelian randomization estimates a genetic proxy for a lifelong tendency toward higher or lower bacteria levels, not what happens when someone actually changes their gut bacteria as an adult. The bacterial groups were analyzed only at the genus or higher taxonomic level, not down to individual species or strains, so it's unclear which specific organisms within groups like Oscillibacter are doing the work. Most participants in both underlying genetic datasets were of European ancestry, so it isn't clear these associations hold in other populations. The effect sizes were also relatively modest, and the authors note there was no independent, sufficiently powered kidney stone dataset available to confirm the results in a second population. A fifth bacterial group, Escherichia-Shigella, showed a similar signal in early analysis but became statistically unstable once the researchers excluded genetic variants with signs of pleiotropy (where a gene variant affects more than one trait at once), so it was dropped from the final four, a sign the team was being conservative rather than overselling their results.

What Comes Next in Gut-Kidney Stone Research

The study's authors are explicit that this is a starting point, not an endpoint, and they lay out a specific path forward. They call for animal studies to confirm that directly manipulating these four bacteria actually changes calcium oxalate crystal formation, followed by prospective human cohort studies that track gut bacteria over time to see whether shifts in these taxa predict who goes on to develop stones. Beyond that, they want to understand the underlying mechanisms, particularly the metabolites these bacteria produce, such as oxalate itself, short-chain fatty acids, or immune-signaling molecules, since that mechanistic work is what would eventually be needed before anyone could target these bacteria therapeutically.

Common Questions

Does this mean a probiotic could prevent kidney stones? Not based on this study. It identifies a genetic association between certain gut bacteria and stone risk, but it doesn't test any probiotic, supplement, or intervention, so no product can be said to replicate these effects.

Which gut bacteria increase kidney stone risk? The genus Olsenella was the one bacterial group linked to higher kidney stone risk in this study, with a 26% higher relative risk per unit increase in genetically predicted abundance.

Is Mendelian randomization the same as a clinical trial? No. It uses genetic variation as a natural experiment to test for likely cause and effect in large populations, but it doesn't involve giving anyone an actual treatment, so it can't substitute for a clinical trial before any recommendation is made.

Why do gut bacteria affect kidney stone formation at all? The leading theory is that gut bacteria influence how much dietary oxalate, a compound found in many plant foods that combines with calcium to form the most common type of kidney stone, gets absorbed into the bloodstream versus broken down in the intestine.

Evidence Rating

EMERGING — 90/100

Caveats

  • This is a Mendelian randomization study, not a clinical trial or observational cohort; the causal claim rests on genetic-instrument assumptions (no reverse causation, no unmeasured pleiotropy), and the authors call the results hypothesis-generating.
  • Bacteria were analyzed only at the genus/class/order level, not species or strain level.
  • Underlying genetic data were predominantly from European-ancestry cohorts, limiting generalizability to other populations.
  • Effect sizes were modest and no independent, sufficiently powered kidney stone dataset was available to validate the findings.

Two-sample Mendelian randomization (genetic-instrument causal inference) using a gut-microbiome GWAS of 18,340 participants against kidney stone GWAS data covering 284,598 cases and 480,873 controls. Four gut bacteria taxa (Lentisphaeria, Oscillibacter, Victivallales, Olsenella) were causally linked to kidney stone risk, with consistent results across multiple sensitivity-analysis methods (weighted median, MR-Egger, MR-PRESSO) and no evidence of reverse causation.

References

  1. Suchun Wang et al. (2026). Assessing the Relationship Between Gut Microbiota and Kidney Stones: A Two-Sample Mendelian Randomization Analysis. PubMed. https://doi.org/10.22037/uj.v23i00.8573
  2. Catherine E Lovegrove, Sarah A Howles, Dominic Furniss, Michael V Holmes (2024). Causal inference in health and disease: a review of the principles and applications of Mendelian randomization. Journal of Bone and Mineral Research. https://doi.org/10.1093/jbmr/zjae136
  3. Definition & Facts for Kidney Stones – NIDDK. NIH. https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones/definition-facts